Health economics is used in clinical trials to ensure information is being collected in the right way so that it can be provided to the minister or committees such as the Pharmaceutical Benefits Advisory Committee so that they can compare new treatments with existing treatments to decide what drugs should be funded in the public system.

We asked Associate Professor De Abreu Lorenco to explain what health economics is, and how it is currently used in clinical trials.